Back to Blog

Traceability Software Failures in Pharma Production

By Covectra | Posted on April 28, 2026

Across pharmaceutical production environments, serialization systems that perform well in validation frequently encounter problems once they reach sustained production. The conditions that expose failure — high line speeds, mixed equipment vintages, operator variability, incremental software updates — are difficult to replicate in a test environment.

Having supported serialization implementations representing over 4 billion serial numbers worldwide, Covectra's engineering teams have a consistent view of where production environments break down — and why. We will take a closer look at these issues in this post.

Key Takeaways

Most traceability software failures originate at integration points between systems — not in the serialization software itself
Aggregation errors are among the most common and least visible failure types in pharmaceutical production
Equipment variability and mixed vendor environments create data reconciliation gaps that compound across production runs
Repackaging and returns workflows are frequently outside the scope of initial serialization implementations, generating chain-of-custody breaks
EPCIS rejection failures tend to go undetected until a verification request is made since no alert is generated at the originating system
Routine audit trail review is the most reliable mechanism for identifying failures before they reach trading partners or regulators

Why Production Environments Expose Traceability Software Failures

Serialization systems are validated under controlled conditions that don't reflect sustained production reality. Line speeds vary, operators override exceptions without logging them, and cameras lose calibration gradually enough that no one notices until read rates have already degraded. Most of these failures don't generate alerts — a missed scan, an unlogged exception, a record posted to the wrong lot enters the data record and stays there until something downstream tries to use it.

How Equipment Variability Creates Systemic Risk

Facilities running mixed equipment vintages carry particular exposure. A packaging line updated incrementally over several years may have an item-level serializer from one vendor, a case aggregation system from another, and a WMS integrated before either existed in their current form.

When the system can't reconcile data in real time — because of inconsistent read rates, timing mismatches, or unlogged exceptions at the case packer — aggregation records become unreliable. A case showing 24 units in the system may physically contain 23 or 25, and those discrepancies follow the product through every subsequent supply chain handoff.

The Six Most Common Traceability System Failure Points

1. Serial Number Generation and Issuance Errors

Serial numbers must be unique, properly formatted, and correctly associated with the physical unit carrying them. In production environments, common generation errors include:

Duplicate SNs issued across production runs
SNs issued but never applied to a physical unit
Formatting failures that make a code unreadable by downstream scanners

These errors only become visible when a trading partner's verification system attempts to match a scanned identifier against the repository and returns an error — at which point the product is already in distribution.

2. Aggregation Data Mismatches

Aggregation — hierarchically linking unit to case to pallet — is how serialization data is structured for supply chain handoffs. In production, aggregation failures typically stem from timing mismatches between the line-level serialization system and the case or pallet aggregation logic, often compounded by manual interventions that bypass automated capture.

When aggregation records are incorrect, the downstream transaction history is compromised for every unit on the affected pallet. The failure is not necessarily obvious at the production stage but becomes apparent when a distributor or dispenser attempts to verify the product and the data doesn't reconcile.

3. ERP/MES/WMS Integration Breakdowns

Serialization data moves through multiple systems before it becomes a usable transaction record — generated on the production floor, recorded by the MES, assigned to a lot by the ERP, and associated with an outbound order by the WMS. Integration failures at any of those handoff points include:

Message queues that back up during peak production
Mapping errors introduced during software updates
Timing mismatches that post records to the wrong lot

These failures can disconnect a physical product from its transaction record without generating any visible alert in either system.

4. Incomplete or Rejected EPCIS Event Files

An EPCIS file that is incomplete — missing required fields, referencing SNs absent from the repository, or formatted for an older schema version than the receiving system expects — will be rejected. Rejections don't always generate alerts at the originating system, and the absence of a confirmed receipt from a trading partner may go unnoticed until a verification request is made months later.

This is one of the more consequential failure types because EPCIS files carry the event history that regulators and trading partners rely on to establish chain of custody. A rejected file that was never resubmitted represents a permanent gap in that record.

5. Repackaging and Returns Without Chain-of-Custody Re-Establishment

Repackaging and returns are among the most underdocumented workflows in pharmaceutical production. Breaking a case, combining partial lots, or transferring product to new packaging all require new serialization events and updated aggregation records. When those steps happen outside the serialization system — or when the system isn't configured to handle repackaging workflows — the chain-of-custody record breaks at that point.

Returns carry the same risk. A product that re-enters inventory without a corresponding serialization event — a new custody record, a repackaging event, or a verification query confirming legitimacy — has an incomplete traceability record from that point forward. These gaps are particularly common in facilities where returns handling was not in scope for the original serialization implementation.

6. Verification Query Failures at the Dispenser Level

Dispensers are required to verify product identifiers against a manufacturer's repository in certain circumstances. Repeated verification query failures — caused by a slow, unavailable, or incorrectly responding endpoint — are often the first indication of a data integrity problem that originated at the manufacturing level considerably earlier.

By the time a pharmacy encounters a verification failure, the underlying data gap has typically been in the system for some time. The dispenser-level failure is a symptom, not the source.

What These Failures Cost

Compliance Exposure

Noncompliance with DSCSA carries significant legal and operational consequences:

Civil fines up to $500,000 per violation — intentional violations can lead to criminal charges including imprisonment
Revocation of manufacturer, wholesaler, and dispenser licenses
Confiscation or recall of illegitimate or non-traceable products
Increased FDA scrutiny and audits
Loss of authorized trading partner relationships

Recall Readiness

In a recall scenario, FDA expects manufacturers to identify every unit in the affected lot within hours — where it was shipped, who received it, and whether it has been dispensed. Systems carrying unresolved aggregation mismatches, rejected EPCIS files, or unreconciled returns cannot produce that data reliably, which means the recall scope has to be defined more broadly than the underlying problem may actually warrant.

Commercial Disruption

Serialization data errors create direct operational and revenue impact:

Shipments a distributor cannot verify against the repository get held at the DC
Products generating query errors get flagged for investigation
Pallets with aggregation mismatches may be refused on receipt

Each event represents delayed revenue, expedited freight costs, and in some cases a lost order. Distributors and large pharmacy chains have limited tolerance for repeated verification failures, and their remediation requests come with firm deadlines.

How Failures Compound Over Time

Technical Debt in Serialization Infrastructure

Many pharmaceutical manufacturers implemented serialization under deadline pressure. The result, across many facilities, is infrastructure that functions adequately under normal conditions but carries undocumented workarounds, integrations that were never properly validated, and exception-handling logic configured at go-live and never revisited.

As trading partner requirements evolve — particularly as EPCIS 2.0 adoption increases — systems built on older architectures will generate more failures. Compliance teams that haven't conducted a systematic review of their serialization infrastructure recently are likely carrying exposure they haven't yet quantified. A broader look at pharmaceutical supply chain security — across packaging, authentication, and distribution controls — can help identify where those gaps sit.

Why Partial Fixes Relocate Rather Than Resolve Failures

When a traceability failure comes to light, the immediate response is usually to address the symptom — the rejected serial number format gets corrected, the aggregation script producing mismatches gets patched. Partial fixes applied without full root cause analysis tend to shift the failure rather than eliminate it. A patch to case-level aggregation logic that doesn't account for pallet-level downstream effects will resolve one mismatch pattern while introducing another.

Resolving traceability software failures reliably requires visibility into the full data flow — from packaging line capture through cloud repository storage and trading partner transmission.

Using Audit Trails to Identify Failures Early

Serialization systems generate substantial audit trail data, including:

Exception logs and read rate reports from the packaging line
Rejected EPCIS transmission logs
Verification query logs from trading partner systems

Most compliance teams review that data reactively, after a dispute or regulatory inquiry. Patterns in exception logs — a specific line generating disproportionate scanner misreads, a trading partner system repeatedly rejecting EPCIS files — are actionable intelligence when reviewed on a routine basis.

Building a Traceability Program That Holds Up Under DSCSA Scrutiny

Serialization programs that hold up under regulatory scrutiny are actively maintained, audited, and integrated properly across the full data chain — from packaging line capture through cloud repository storage and trading partner verification.

Covectra's AuthentiTrack is an EPCIS-certified serialization and track-and-trace platform with a serial event history repository and a secure data gateway for trading partner interoperability. Our pharmaceutical serialization services include integration support, systems assessment, and a Verification Router Service for saleable returns compliance.

Talk to Covectra's pharmaceutical serialization team →

Frequently Asked Questions About Traceability System Failures in Production

Where do traceability systems most commonly break in pharmaceutical production environments?

The most common failure points are ERP/MES/WMS integration handoffs, aggregation logic mismatches at the case and pallet level, and EPCIS event file generation and transmission. These failures tend to originate at the boundaries between systems rather than within any single platform, which makes them harder to detect and attribute.

Why do aggregation errors go undetected for so long in production environments?

Aggregation errors typically produce no visible output at the production stage — the line continues running, the system logs a record, and the physical product moves forward. The error becomes apparent only when a downstream system attempts to reconcile the aggregation data against physical reality, usually at a distributor DC or during a regulatory verification request.

Can a serialization system pass validation and still generate production failures?

Yes. Validation testing is conducted under controlled conditions with ideal inputs. Production introduces variables — line speed variation, operator interventions, equipment timing drift — that validation doesn't replicate. A system that performs correctly in testing may generate consistent failures under sustained production conditions, particularly at integration handoff points.

How do repackaging workflows create traceability gaps?

Repackaging requires new serialization events and updated aggregation records. When those steps happen outside the serialization system — through manual processes or workflows the system wasn't configured to handle — the chain-of-custody record breaks at that point. Products that were repackaged without corresponding serialization events will generate verification failures when trading partners or regulators attempt to trace them.

What is the most effective way to detect traceability software failures before they affect trading partners?

Routine review of audit trail data — exception logs, EPCIS transmission logs, and verification query logs — is the most reliable detection mechanism. Failures that would otherwise remain invisible until a trading partner raises a flag tend to leave consistent patterns in exception and transmission data well before they escalate.